Original Research

COVID-19 and Thyroid Illness

DOI https://doi.org/10.70302/jpsim.v3i3.2242
Received: 09 Apr 2022 Accepted: 04 Jul 2022 Published Online: 12 Sep 2022

Abstract

Objective

We present a case series of three cases of thyroid dysfunction such as Hashimoto thyroiditis, Graves’ disease and sub acute thyroiditis presenting in few weeks after resolution of acute phase of COVID -19 infection in patients with no prior thyroid disease. Physicians should be acquainted with possible relationship of COVID-19 and thyroid dysfunction.

Methods

We discuss clinical manifestation, diagnostic evaluation and ensuing management and follow-up in each patient having thyroid dysfunction after getting positive for covid-19.

Conclusion

The temporal relationship highlights the association of different forms of thyroid dysfunction with COVID-19 calling for further research to clarify the connections and answers to many questions.

Keywords
COVID-19 thyroid dysfunction various non-thyroidal illness syndrome subacute thyroiditis Graves' disease hashimoto thyroiditis

How to Cite This Article

Latif H, Iqbal A, Farooq N, Rathore R. COVID-19 and Thyroid Illness. J Pak Soc Intern Med. 2022;3(3):216–219. doi:10.70302/jpsim.v3i3.2242

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Caron P. Thyroid disorders and SARS-CoV-2 infection: from pathophysiological mechanism to patient management. Ann Endocrinol (Paris). 2020;81(5):507-10.
  2. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18):1708-20.
  3. Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest 2020; 43(7):1027-31.
  4. Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J Pathol 2004;203(2):622-30.
  5. Desailloud R, Hober D. Viruses and thyroiditis: An update. Virol J. 2009;6(1):5.
  6. Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine 2020; doi: https://doi.org/10.1007/s12020-020-02364-8. doi:10.1007/s12020-020-02364-8
  7. Bellastella G, Maiorino MI, Esposito K. Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands? J Endocrinol Invest 2020:1–2. https:// doi.org/10.1007/s40618-020-013118. doi:10.1007/s40618-020-013118
  8. Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;doi: https://doi.org/10.1007/s40618-020-01276-8. doi:10.1007/s40618-020-01276-8
  9. Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty.2020;9(1):45.
  10. Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J Pathol 2004;203(2):622-30.
  11. Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol 2020;153(6):725-33.
  12. Bradley BT, Maioli H, Johnston R, Chaudhry I, Fink SL, Xu H, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. Lancet 2020;396(10247):320-32.
  13. Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST, et al. Detection of SARS-COV-2 receptor ACE- 2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021;44(5):1085-90.
  14. Lania A, Sandri MT, Cellini M, et al. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020;183(4):381-7.
  15. Idrose AM. Acute and emergency care for thyrotoxicosis and thyroid storm. Acute Med Surg. 2015;2(3):147-57.
  16. Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.
  17. Muller I, Cannavaro D, Dazzi D, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8(9):739-41.
  18. Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2020; doi: https://doi.org/10.1007/s1115. doi:10.1007/s1115
  19. Bellastella G, Maiorino MI, Esposito K. Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands? J Endocrinol Invest. 2020;43(8):1169-1170.
  20. Croce L, Gangemi D, Ancona G, Liboà F, Bendotti G, Minelli L, et al. The cytokine storm and thyroid hormone changes in COVID-19. J Endocrinol Invest 2021;44(5):891- 904.
  21. Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: THE THYRCOV STUDY. Eur J Endocrinol 2020;183(4):381-7.
  22. Chen M, Zhou W, Xu W. TThyroid function analysis in 50 patients with COVID-19: A retrospective study. Thyroid 2021; 31(1):8-11.
  23. Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, et al. Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab 2021;106(10):e926–35.
  24. Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19. J Endocrinol Invest 2020;43(12):1527–8.
  25. Nishihara E, Ohye H, Amino N, Takata K, Arishima T, Kudo T, et al. Clinical Characteristics of 852 Patients With Subacute Thyroiditis Before Treatment. Intern Med. 2008; 47(8):725–9.
  26. Benbassat CA, Olchovsky D, Tsvetov G, Shimon I. Subacute Thyroiditis: Clinical Characteristics and Treatment Outcome in Fifty-Six Consecutive Patients Diagnosed Between 1999 and 2005. J Endocrinol Invest. 2007;30(8):631–5.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2022 Journal of Pakistan Society of Internal Medicine.